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Pregnancy-associated plasma protein-A (PAPP-A), a
macromolecular glycoprotein of placenta] origin, was reported
to be depressed in established ectopic pregnancies. CA 125
is a known marker for ovarian cancer found to be elevated
during the first trimester of pregnancy and in women with
pelvic inflammatory disease. The present study investigated
the usefulness of these parameters to predict the outcome of
pregnancy in asymptomatic patients with a positive pregnancy
test after in-vitro fertilization and embryo transfer (IVF-ET).
Blood samples (n = 159) were obtained at different periods
of time post-ET from 39 women, 21 of whom experienced
a normal pregnancy, 12 had an intrauterine abortion and six
had an ectopic pregnancy. PAPP-A and CA 125 were
measured by radioimmunoassays. From day 30 onwards in
normal pregnancies, PAPP-A was significantly increased over
non-pregnant controls. In the spontaneous abortion group,
the levels of PAPP-A were significantly lower than in normal
pregnancy but higher than in non-pregnant controls. In
ectopic pregnancy, PAPP-A remained at the level of non-
pregnant controls throughout the entire observation period.
CA 125 was significantly increased in all types of pregancy.
However, in two cases of hyperstimulation followed by a
normal pregancy and in four cases of ectopic pregnancy with
signs of peritoneal irritation (hydrosalpinx, ruptured ectopic
or salpingitis) the levels of CA 125 were 15-50 times higher
than in normal pregnancies. PAPP-A levels < 10th percentile,
measured after 30 days post-ET, were an excellent diagnostic
parameter for ectopic pregnancy or intrauterine abortion with
a sensitivity of 87.5% and a predictive value of disease of
100%. In contrast, CA 125 determinations had no diagnostic
value and were only indicative of peritoneal inflammation in
either normal or pathological pregnancies. It is concluded that
PAPP-A is a good parameter by which to monitor post-
implantation viability of embryos in FVF-ET patients.
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Introduction
Pregnancy-associated plasma protein-A (PAPP-A) is a
trophoblastic, macromolecular glycoprotein (Mr 800 000)
produced in increasing concentrations into the maternal circulation
as pregnancy advances (Folkersen et al., 1981; Bischof et al.,
1982). The biological function of PAPP-A is unknown so far,
but Sinosich et al. (1982) reported that PAPP-A is a specific
inhibitor of human granulocyte elastase. Several clinical studies
have investigated the usefulness of PAPP-A measurements during
pregnancy (Stabile et al., 1988). In first-trimester pregnancies
with an ultrasonically proven live fetus, low PAPP-A levels had
a 49% predictive value of fetal demise with a sensitivity of 89%
(Westergaard, 1987). In ectopic pregnancies, most authors found
very depressed (<10th centile) or even unmeasurable
concentrations of PAPP-A (Grudzinskas et al., 1984; Sjoberg,
1987; Tornehave et al., 1987) whereas in a similar study with
a different design, we found only slightly depressed PAPP-A
levels (Bischof et al., 1983).
CA 125 is an antigenic determinant defined by a monoclonal
antibody (OC 125) raised against an ovarian carcinoma cell line
(Bast et al., 1981). The structure and function of CA 125 are
unknown. CA 125 appears to be the most useful marker for
ovarian carcinoma with a reported sensitivity of >80% and a
concordance with the disease status of 93% (Bast et al., 1983;
Brioschi et al., 1987). During early preganncy, high CA 125
levels were detected during the first trimester but not thereafter
(Niloff etai, 1984; Seki etal, 1986).
Since CA 125 has been localized immunohistochemically in
mesothelial cells of the peritoneum (Kabawat et al., 1983) and
since CA 125 is elevated in pelvic inflammatory disease (Niloff
et al., 1984; Halila et al., 1986), it was of interest to see if CA
125 could be of any help in the diagnosis and follow-up of ectopic
pregnancies (if they induce a peritoneal irritation) and if the
clinical usefulness was similar to PAPP-A measurements.
Patients and methods
Blood samples (n = 159) collected onto ethylene-diamine tetra-
acetic acid (EDTA) were obtained at various periods of time
[10-40 days from embryo transfer (ET)] in 39 women with a
positive pregnancy test following IVF and ET. Follicular
maturation was induced by a protocol which has already been
described (Zorn etal., 1988). When oestradiol levels were
> 1000 pg/ml and when at least two follicles > 15 mm could
be seen at ultrasound, ovulation was induced by 5000 IU of
human chorionic gonadotrophin (HCG). Oocytes were collected
36 h after induction and fertilization occurred in vitro in medium
B2 (Menezo, Abisystem France). Embryos (one to five) were
re-implanted 48 h later and HCG (1500 IU) was given 1 and/or
3 or 5 days post-ET. The patients were followed thereafter by
ultrasound. The day of ET was considered to be day 0 of
pregnancy.
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Fig. 1. Individual PAPP-A values according to the outcome of pregnancy.
Table I. PAPP-A and CA 125 concentrations according to the type of pregnancy and time after ET
Non-pregnant PAPP-A ng/ml ± SEM
controls (n)
< 20 days 21 - 30 days 31 - 4 0 days
Non-pregnant CA 125 U/ml ± SEM
controls (n)
<20 days 21-30 days 31-40 days
Non pregnant
Normal pregnancy
Normal pregnancy
with hyperstimulation
73 3 ± 3.5
(13)
(5)
21.4 ± 7 3e
(13)
Abortion
Ectopics
Ectopics with
peritoneal irritation
75.0 ± 1.6" 130.4 ± 4.8b 279.2 ± 69.2
(36) (19) (10)
83.0 ± 6.0
(5) (I)
79.0 ± 2.6 85.6 ± 2.9C 129.3 ± 22.3d
(28) (17) (9)
80.8 ± 4.4 80.8 ± 5 6 97.7 ± 10.4
(6) (4) (3)
81 2 ± 4.6 80.7 ± 3.3 116.3 ± 13.8
(II) (6) (3)
164.3 ± 25.5f 152 7 ± 36.7 60.4 ± 20.18
(26) (18) (8)
3683.8 ± 36O.2h
(5)
115.8 ± 19.0 116.7 ± 32.3 88.4 ± 25.3
(23) (12) (7)
71.2 ± 10.01 39.3 ± 5.9 19.3 ± 4.8k
(5) (4) (3)
10332 ± 261.8J 2111.3 ±420.4 1627.3 ± 439.0
(9) (6) (3)
"versus bP < 0 0005. cversus aP < 0.001; eversus fP < 0 0005; Versus 8P < 0.03; Versus hP < 0.0005; Versus 'ns; 'versus >P < 0.01: ^versus kns.
In addition, EDTA plasma was obtained during the luteal phase
(days 19—25) from 13 normal volunteers with regular cycles.
None was under hormonal therapy. These women served as a
control group.
PAPP-A was measured by radioimmunoassay according to a
method published elsewhere (Bischof et ai, 1981; Bischof and
Meisser, 1989). CA 125 measurements were performed with a
commercially available immunoradiometric assay (Centocor CA
125™, Medipro AG, Teufen, Switzerland). Results were
ranked according to the length of gestation and according to the
outcome of pregancy: normal pregnancy (n = 21, 72 samples),
first trimester abortions (n = 12, 54 samples) and ectopic
pregnancy (n = 6, 33 samples). No samples were available after
spontaneous abortion had occurred.
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Fig. 2. Individual CA 125 values according to the outcome of
pregnancy.
Statistical analysis was performed by computer using the SPSS
(Statistical Package for Social Sciences) program. Regression
analysis and Student's /-test for paired or unpaired variables were
used when appropriate, and the median and 10th and 90th
percentiles calculated from the group of normal pregnant patients.
Diagnostic parameters (sensitivity, specificity and predictive
value) were calculated for CA 125 >90th percentile and for
PAPP-A < 10th percentile according to an established method
(Galen and Gambino, 1975).
Results
Individual values of PAPP-A for all three groups of pregnancies
are shown in Figure 1. Irrespective of the type of pregnancy
eventually diagnosed (normal, spontaneous abortion or ectopic
pregnancy), the levels of PAPP-A remained low and unchanged
up to 25-28 days after ET. After 30 days all nine patients, for
whom blood was available and who experienced a normal
pregnancy, had increased levels of PAPP-A (compared with non-
pregnant controls; Figure 1, Table I). Only two out of six patients
who spontaneously miscarried and for whom samples were
available after 30 days showed an increase in PAPP-A after 30
days (Figure 1). None of the five patients (with blood samples
Day of First high
diagnosis value of CA125
from ET days from ET
1 Normal pregnancy, hyperstimulation
at USa 2
2 Normal pregnancy, hyperstimulation
and ascites. US and clinical signs 12
3 Suspicion of ectopic preganncy at US 14
Salpingitis diagnosed at surgery 33
Ruptured ectopic pregnancy,
blood collection 23
Suspicion of ecotpic pregnancy at US 36
Hydrosalpinx at surgery 55
Suspicion of ectopic pregnancy at US 40
Ruptured ectopic pregnancy at surgery 70
14b
, 9 b
10
12
"Ultrasound
bNo blood samples were available before.
after 30 days) in whom an ectopic pregnancy was diagnosed had
an increase in PAPP-A (Table I).
Individual CA 125 values are shown in Figure 2. High CA
125 levels were observed in all groups between 10 and 20 days
after ET. After 20 days, the levels decreased in normal
pregnancies and in the group of spontaneous abortions, whereas
only two out of six patients with ectopic pregnancies showed a
decrease in CA 125. Two patients with normal pregnancies and
four patients with ectopic pregnancies had very high levels of
CA 125 throughout the observation period. All these patients
showed, at one time or another, clinical and/or ultrasound signs
of peritoneal irritation (Table II), due either to hyperstimulation
(two cases of normal pregnancy) or to ruptured ectopic pregnancy
(two cases), to hydrosalpinx (one case) or to salpingitis (one case).
In the four cases of ectopic pregnancy, high CA 125 levels were
recorded 4 - 3 0 days before the pathology could be diagnosed
(Table II). In the two cases of normal pregnancy, no blood
samples were available before the date of diagnosis of
hyperstimlation.
A further evalution was performed by ranking the CA 125 and
PAPP-A values according to the type of pregnancy and according
to the length of gestation (Table I).
In normal pregnancies and up to 20 days after ET, the levels
of PAPP-A were similar to the non-pregnant controls. However,
PAPP-A was significantly (P < 0.0005) increased in the groups
of 21-23 days and 31-40 days. The mean time at which
PAPP-A was found to be significantly higher than the
non-pregnant controls (> mean + 2 SD) was 27.2 ± 1.1. day
(mean ± SEM, n = 14). In the group of spontaneous abortions,
PAPP-A levels remained comparable to the non-pregnant group
up to 30 days and increased significantly thereafter (P < 0.01)
to levels which were about half of those in normal pregnancies.
No significant increase was seen in ectopics either with or without
peritoneal irritation, so that the concentrations of PAPP-A
remained at the level of non-pregnant controls up to 40 days after
ET.
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Table III. Diagnostic parameters of CA 125 and PAPP-A in ectopic pregnancies and/or spontaneous abortions
Period of
gestation
(days)
Detection of
ectopics if
CA 125 > 90th centile"
Detection of ectopics or
spontaneous abortions if
PAPP-A < 10th centilea
Sensitivity
of the tests
Specifity
of the tests
Predictive value for
the disease
Predictive value for
absence of disease
<20
21-30
31-40
<20
21-30
31-40
<20
21-30
31-40
<20
21-30
31-40
50
66 7
50 0
86.2
86.4
75.0
42.9
57.1
40 0
89.3
90.5
81.8
0
35.3
87.5
94.7
100
100
0
100
100
50.0
57.7
88.9
"All measured values were considered in the calculation and not only one per patient.
CA 125 levels in normal pregnancies were significantly higher
(P < 0.0005) than in non-pregnant controls throughout the entire
observation period (10-40 days after ET). However, they were
significantly (P < 0.0005) lower between 31 and 40 days than
before. In normal pregnancies with hyperstimulation, the
concentrations of CA 125 were —20 times higher than in normal
pregnancies without hyperstimulation (Table I). Spontaneous
abortions and ectopic pregnancies without peritoneal irritation
had CA 125 levels which were not statistically different from
ongoing pregnancies. In ectopic pregnancies with peritoneal
irritation, the levels of CA 125 were 15-50 times higher than
in ectopic pregnancies which had no signs of peritoneal irrita-
tion (Table I).
Table in gives the diagnostic parameter for ectopic pregnancies
and spontaneous abortions if PAPP-A < 10th percentile. The
diagnostic potency of these tests depended on the duration of
pregnancy: the sensitivity of PAPP-A < 10th percentile was
acceptable for pregnancies of > 30 days from ET but not before
(Table III). The first values of PAPP-A < 10th centile were
observed between days 29 and 33 of pregnancy. Under these
conditions, the specificity and predictive value for the disease
were 100%, whereas the predictive value for the absence of the
disease was 88.9%. The diagnostic parameters for CA 125 were
not as good as those for PAPP-A (Table I). The predictive value
for the disease was between 40 and 57% depending on the
duration of pregnancy. The specificity and sensitivity were also
poor. However, the predictive value for absence of disease was
acceptable (81.8-90.5%).
Discussion
Several pregnancy proteins have been evaluated in the search for
a specific biochemical marker of ectopic pregnancy. PAPP-A
is certainly the most promising, since several studies reported
depressed or even undetectable PAPP-A levels in women with
established ectopic pregnancies (Grudzinskas etai, 1984;
Sjoberg, 1987; Tornehave et al., 1987). In asymptomatic patients
after IVF-ET (Sinosich et al., 1983, 1985), it was reported that
in threatened abortions in the presence of a live fetus, PAPP-A
levels were consistently depressed and that the sensitivity of such
a test was 91.7% (Sinosich et al., 1985). In the present study
using a similar design (samples collect prospectively but earlier
on a larger group of 39 consecutive asymptomatic patients), we
obtained a sensitivity of 87.5% for PAPP-A levels being below
the 10th percentile in pregnancies between 30 and 40 days after
ET. Before 30 days, PAPP-A measurements are not useful.
Despite the fact that with this test, no distinction can be made
between ectopic pregnancies and intra-uterine abortions, PAPP-
A is certainly an excellent parameter by which to monitor post-
implantation viability of embryos. In the present study, and in
contrast to other studies (Grudzinskas et al., 1984; Sjoberg, 1987;
Tornehave et al., 1987), PAPP-A levels were depressed in
ectopic pregnancies but never below the sensitivity of the assay
and were even measurable in non-pregnant women. As reported
recently (Bischof and Meisser, 1989), this difference is due to
the immunological heterogeneity of PAPP-A and to the fact that
we use EDTA plasma samples and standards.
When compared with non-pregnant controls, CA 125 levels
were reported to be significantly higher during the first trimester
of pregnancy but not thereafter (Niloff et al., 1984; Halila et al.,
1986; Seki et al., 1986). In early pathological pregnancies, CA
125 measurements have not heretofore been reported. In the
present study, CA 125 levels were significantly increased during
early normal and pathological pregnancy. In the group of patients
ending their pregnancy by a spontaneous abortion, the levels of
CA 125 were similar to normal pregnancies. However, whenever
signs of peritoneal irritations were present (hyperstimulation in
normal pregnancies or ruptured ectopic pregnancies), the values
of CA 125 were dramatically increased days before the pathology
was evident. Increased CA 125 levels, however, have no
diagnostic value for ectopic pregnancies, since normal values can
be found in this group (those without peritoneal irritation) and
increased values were found in normal pregnancy with
hyperstimulation. A very high level of CA 125 in early
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pregnancy, either in normal or in pathological pregnancies (before
30 days from ET), is thus only indicative of peritoneal
inflammation. This raises the question of the origin of CA 125.
We have produced evidence in vitro (Bischof et al., 1986) that
CA 125 could be produced by the endometrium, thus providing
an explanation for the increased CA 125 levels during
endometriosis. The present observations, however, tend to
atttribute the origin of CA 125 in pregnant women to the fetus
and/or to the peritoneal wall, an observation which would fit with
the tissue distribution of CA 125 as reported by Kabawat et al.
(1983).
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